Last reviewed · How we verify
NCT01094418
A Observational Cross Sectional Study to Evaluate the Sensory Nerve Conduction Parameters of the Distal Sensory Nerves in Patients With Impaired Glucose Tolerance and Diabetes Mellitus
trial testing Nerve conduction studies ( NCS) of the peripheral nerves in Impaired Glucose Tolerance in 150 participants. Completed in 1 February 2010.
1 February 2010
Quick facts
| Lead sponsor | The Catholic University of Korea |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 June 2009 |
| Primary completion | 1 February 2010 |
| Estimated completion | 1 February 2010 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Nerve conduction studies ( NCS) of the peripheral nerves
Conditions studied
- Impaired Glucose Tolerance — all drugs for Impaired Glucose Tolerance →
- Peripheral Polyneuropathy — all drugs for Peripheral Polyneuropathy →
- DM — all drugs for DM →
Sponsor
The Catholic University of Korea
Who can join
Adults 20 to 70, any sex, with Impaired Glucose Tolerance or Peripheral Polyneuropathy. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Nerve conduction parameters
Time frame: NCS performed once, within one day after enrollment
Nerve conduction study (NCS) parameters of the dorsal sural, medial dorsal cutaneous and medial plantar nerves, along with standard NCS of the tibial and peroenal motor, sural, superficial peronea, median and radial sensory nerves.
Sponsor's own description
The purpose of this study is to evaluate the distal sensory nerves of the feet, namely, the dorsal sural, medial dorsal cutaneous and medial plantar nerves, in patients with impaired glucose tolerance and diabetes mellitus type 2 and compare these parameters to those from healthy participants.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Assessment of the medial dorsal cutaneous, dorsal sural, and medial plantar nerves in impaired glucose tolerance and diabetic patients with normal sural and superficial peroneal nerve responses.
Im S, Kim SR, Park JH, Kim YS, et al · · 2012 · cited 21× · PMID 22100966 · DOI 10.2337/dc11-1001
Verify or expand the search:
- PubMed search for NCT01094418
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Impaired Glucose Tolerance
Currently open trials in the same condition.
- NCT06964620 — Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diab · EARLY_PHASE1 · recruiting
- NCT06507722 — Night Owl Metabolism · NA · recruiting
- NCT05912348 — The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults · NA · recruiting
- NCT05873322 — Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents Wi · recruiting
Other The Catholic University of Korea trials
Trials by the same sponsor.
- NCT06367998 — Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair · Phase 4 · not yet recruiting
- NCT07174544 — Mobile Self-Management Program for Stress Reduction in Young Adults · NA · completed
- NCT05671705 — Effect of Sarcopenia in Stroke Patients · completed
- NCT05509244 — Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Laparoscopic Gynecology Surgery · NA · unknown
- NCT05539690 — Effect of Balance Training on White Matter Tracts in Healthy Elderly Population · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01094418 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Catholic University of Korea
- Last refreshed: 26 March 2010
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01094418.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing